Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

126.30
Data as of Jan 27
 -0.70 / -0.55%
Today’s Change
86.00
Today|||52-Week Range
172.98
+9.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues257.6M384.4M382.0M354.7M
 
 
 
 
 
 
Operating ExpensesGross Income189.5M213.9M222.8M213.4M
 
 
 
 
 
Total Operating Expenses184.8M332.0M344.3M357.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income72.8M52.4M37.7M-3.1M
 
 
 
 
 
Extraordinary Credit23.2M0.000.00--
 
 
Extraordinary Charge0.00-90.4M-50.5M-76.5M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income81.3M-80.2M6.0M-125.0M
 
 
 
 
 
Income Taxes-29.0M-36.4M-2.7M-36.4M
 
 
 
 
 
Net Income52.3M-43.9M3.3M-88.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS62.9M63.3M63.4M63.7M
 
 
 
 
 
Shares To Calculate EPS Diluted69.1M63.3M75.5M63.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.76-$0.69$0.04-$1.39
 
 
 
 
 
EPS Diluted----------
 

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.